+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals



The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals



Journal of Virus Eradication 5(1): 60-66



Hepatitis B virus (HBV) and hepatitis C virus (HCV) affect more than 320 million people worldwide, which is more than HIV, tuberculosis (TB) and malaria combined. Elimination of HBV and HCV will, therefore, produce substantial public health and economic benefits and, most importantly, the prevention of 1.2 million deaths per year. In 2016, member states of the World Health Assembly unanimously adopted a resolution declaring that viral hepatitis should be eliminated by 2030. Currently, few countries have elimination programmes in place and even though the tools to achieve elimination are available, the right resources, commitments and allocations are lacking. During the fifth International Viral Hepatitis Elimination Meeting (IVHEM), 7-8 December 2018, Amsterdam, the Netherlands, an expert panel of clinicians, virologists and public health specialists discussed the current status of viral hepatitis elimination programmes across multiple countries, challenges in achieving elimination and the core indicators for monitoring progress, approaches that have failed and successful elimination plans.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 066527411

Download citation: RISBibTeXText

PMID: 30800429


Related references

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework. Journal of Virus Eradication 4(3): 193-195, 2018

Meeting the WHO and US Goals to Eliminate Hepatitis B Infection by 2030: Opportunities and Challenges. Clinical Liver Disease 12(1): 29-32, 2019

Monitoring the Who-Recommended Core Indicators for Viral Hepatitis B and C in EU/EEA Member States: Supporting the Global Vision of Elimination. Journal of Hepatology 64(2): S214-S215, 2016

Implementing the WHO Global Health Sector Strategy on Viral Hepatitis in Denmark modeling the effects of community-based care on the elimination of HCV by 2030. Journal of Hepatology 66(1): S413-S414, 2017

Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030. Journal of Gastroenterology and Hepatology 2018, 2018

Towards elimination of viral hepatitis by 2030. Lancet 388(10042): 308, 2016

Elimination of viral hepatitis by 2030: ambitious, but achievable. Lancet. Gastroenterology & Hepatology 4(2): 88-89, 2019

Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks. Journal of Epidemiology and Community Health 70(12): 1151-1154, 2016

Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers. Jmir Public Health and Surveillance 3(4): E91, 2017

Hepatitis C core antigen testing: Still an effective diagnostic method for global elimination of hepatitis C. Clinical Infectious Diseases 2019, 2019

The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts. Lancet 388(10049): 1030-1031, 2016

Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions. Euro Surveillance 22(9), 2017

"Towards eliminating viral hepatitis": Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination. International Journal on Drug Policy 2019, 2019

Micro-elimination of hepatitis C virus infection in β-Thalassaemia major patients: Positively moving towards the World Health Organisation 2030 eradication goal. Digestive and Liver Disease 2019, 2019

Micro-elimination - A path to global elimination of hepatitis C. Journal of Hepatology 67(4): 665-666, 2017